17 U.S. lawmakers have disclosed 36 CME Group Inc. trades under the STOCK Act — 19 buys and 17 sells between 2013 and 2026. Congress has been net buyers of CME, and their disclosed buys are up 5.4% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of CME, marked to the latest close — per-share (share counts aren't disclosed).
Lawmakers ranked by notional-weighted return on their disclosed CME buys (last ~3y), marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-06-16 | Gilbert Cisneros | SELL | $1K–$15K | $261.60 | $267.21 2026-08-13 | -2.1% exit |
| 2026-03-27 | Alan Armstrong | BUY | $1K–$15K | $293.78 | $267.21 2026-08-13 | -9.0% |
| 2025-07-22 | Julie Johnson | BUY | $1K–$15K | $274.64 | $267.21 2026-08-13 | -2.7% |
| 2025-03-10 | Carol Devine Miller | BUY | $1K–$15K | $262.28 | $267.21 2026-08-13 | +1.9% |
| 2024-01-17 | Thomas R Carper | BUY | $1K–$15K | $202.97 | $267.21 2026-08-13 | +31.6% |
| 2023-12-06 | Michael C. Burgess | SELL | $15K–$50K | $214.25 | $267.21 2026-08-13 | +3.7% rt |
| 2023-08-09 | Michael C. Burgess | BUY | $15K–$50K | $206.52 | $267.21 2026-08-13 | +29.4% |
| 2023-01-11 | Thomas R Carper | BUY | $1K–$15K | $175.64 | $267.21 2026-08-13 | +52.1% |
| 2022-06-10 | Kathy Manning | SELL | $15K–$50K | $199.90 | $267.21 2026-08-13 | -33.7% exit |
| 2022-05-27 | Kathy Manning | SELL | $1K–$15K | $199.93 | $267.21 2026-08-13 | -33.6% exit |
| 2022-03-03 | Kathy Manning | SELL | $1K–$15K | $240.82 | $267.21 2026-08-13 | -11.0% exit |
| 2021-12-14 | Robert J. Wittman | SELL | $1K–$15K | $227.55 | $267.21 2026-08-13 | -17.4% exit |
| 2020-09-23 | Dean Phillips | BUY | $1K–$15K | $162.35 | $267.21 2026-08-13 | +64.6% |
| 2020-07-01 | John A. Yarmuth | SELL | $1K–$15K | $168.90 | $267.21 2026-08-13 | -58.2% exit |
| 2020-06-08 | John A. Yarmuth | SELL | $1K–$15K | $191.75 | $267.21 2026-08-13 | +43.3% rt |
| 2020-04-07 | Kelly Loeffler | SELL | $100K–$250K | $176.81 | $267.21 2026-08-13 | -19.7% rt |
| 2020-03-19 | Kelly Loeffler | BUY | $50K–$100K | $155.22 | $267.21 2026-08-13 | +72.2% |
| 2020-03-16 | Kelly Loeffler | SELL | $15K–$50K | $148.54 | $267.21 2026-08-13 | -29.0% rt |
| 2020-02-28 | Kelly Loeffler | SELL | $50K–$100K | $198.82 | $267.21 2026-08-13 | -5.0% rt |
| 2020-02-26 | Kelly Loeffler | BUY | $100K–$250K | $220.18 | $267.21 2026-08-13 | +21.4% |
| 2020-02-26 | Kelly Loeffler | BUY | $100K–$250K | $220.18 | $267.21 2026-08-13 | +21.4% |
| 2020-02-24 | Kelly Loeffler | BUY | $50K–$100K | $209.30 | $267.21 2026-08-13 | +27.7% |
| 2020-02-24 | Kelly Loeffler | BUY | $50K–$100K | $209.30 | $267.21 2026-08-13 | +27.7% |
| 2019-09-11 | Mikie Sherrill | SELL | — | $202.58 | $267.21 2026-08-13 | -31.9% exit |
| 2019-03-11 | Shelley M Capito | SELL | $1K–$15K | $170.82 | $267.21 2026-08-13 | -56.4% exit |
| 2018-11-28 | Rohit Khanna | BUY | $1K–$15K | $187.11 | $267.21 2026-08-13 | +42.8% |
| 2018-08-02 | Pete Sessions | BUY | $15K–$50K | $161.04 | $267.21 2026-08-13 | +65.9% |
| 2018-04-24 | Shelley M Capito | SELL | $15K–$50K | $161.60 | $267.21 2026-08-13 | +26.2% rt |
| 2018-04-24 | Shelley M Capito | SELL | $15K–$50K | $161.60 | $267.21 2026-08-13 | -65.3% exit |
| 2017-09-20 | John A. Yarmuth | BUY | $1K–$15K | $133.80 | $267.21 2026-08-13 | +99.7% |
| 2017-09-08 | Shelley M Capito | BUY | $1K–$15K | $128.04 | $267.21 2026-08-13 | +108.7% |
| 2016-12-22 | James B. Renacci | BUY | $1K–$15K | $120.69 | $267.21 2026-08-13 | +121.4% |
| 2014-07-23 | Susan M Collins | BUY | $1K–$15K | $74.88 | $267.21 2026-08-13 | +256.9% |
| 2014-07-23 | Susan M Collins | BUY | $1K–$15K | $74.88 | $267.21 2026-08-13 | +256.9% |
| 2014-01-21 | SUSAN M COLLINS | SELL | $1K–$15K | $75.73 | $267.21 2026-08-13 | -252.8% exit |
| 2013-06-24 | SUSAN M COLLINS | SELL | $1K–$15K | $76.06 | $267.21 2026-08-13 | -251.3% exit |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
17 members of the U.S. House and Senate have disclosed CME Group Inc. transactions under the STOCK Act — 19 purchases and 17 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a CME purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed CME buys are up 5.4% versus the latest close of $267.21. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded CME and how it performed.